Viewing Study NCT03591666


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-26 @ 11:17 AM
Study NCT ID: NCT03591666
Status: UNKNOWN
Last Update Posted: 2018-07-19
First Post: 2018-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module